1. Minimally Invasive Video-Assisted Thyroidectomy: Analysis of Complications From a Systematic Review
- Author
-
Gianfranco Cocorullo, Roberta Tutino, T Fontana, G Rotolo, C Raspanti, Gregorio Scerrino, Calogero Porrello, L Licari, Gaspare Gulotta, Giuseppe Salamone, G. Melfa, Scerrino, Gregorio, Melfa, Giuseppina, Raspanti, Cristina, Rotolo, Giulia, Salamone, Giuseppe, Licari, Leo, Fontana, Tommaso, Tutino, Roberta, Porrello, Calogero, Gulotta, Gaspare, and Cocorullo, Gianfranco
- Subjects
definitive complication ,medicine.medical_specialty ,business.industry ,transient complications ,medicine.medical_treatment ,review ,Thyroidectomy ,Video-Assisted Surgery ,MIVAT ,Surgery ,03 medical and health sciences ,Video assisted thyroidectomy ,Postoperative Complications ,0302 clinical medicine ,minimally invasive video-assisted thyroidectomy ,030220 oncology & carcinogenesis ,Humans ,Minimally Invasive Surgical Procedures ,Medicine ,030211 gastroenterology & hepatology ,Complication rate ,business ,conventional thyroidectomy - Abstract
Background. Nowadays, minimally invasive video-assisted thyroidectomy (MIVAT) is considered a safe and effective option. However, its complication rate has not been specifically discussed yet. The aim of this systematic review was enrolling a large number of studies to estimate early and late complications (transient and definitive, uni- and bilateral laryngeal nerve palsy; transient and definitive hypocalcemia; cervical hematoma; hypertrophic or keloid scar) of MIVAT compared with conventional technique. Methods. The review was performed according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) criteria in PubMed and Embase. Search terms were “minimally invasive,” “video-assisted,” and “thyroidectomy.” We enrolled randomized clinical trials, nonrandomized trials, and noncontrolled trials. Results. Thirty-two articles were considered suitable. Complication rate of MIVAT was quite similar to conventional technique: only one randomized trial found a significant difference concerning overall skin complication, and a single trial highlighted hypocalcemia significantly increased in MIVAT, concerning serologic value only. No difference concerning symptomatic nor definitive hypocalcemia was found. Conclusions. We can confirm that MIVAT is a safe technique. It should be adopted in mean-high-volume surgery centers for thyroidectomy, if a strict compliance with indication was applied.
- Published
- 2019
- Full Text
- View/download PDF